|
|||||
|
|
Remdesivir in COVID-19 Patients with Impaired Renal Function |
|
| Authors: | Sanna Gevers Jan Welink Cees van Nieuwkoop |
| Affiliation: | 1.Dutch Medicines Evaluation Board, Utrecht, The Netherlands;2.Department of Internal Medicine, Haga Teaching Hospital, The Hague, The Netherlands |
| Abstract: | |
| Keywords: | nephrotoxicity COVID-19 |